<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04528979</url>
  </required_header>
  <id_info>
    <org_study_id>UICENDECL201703</org_study_id>
    <nct_id>NCT04528979</nct_id>
  </id_info>
  <brief_title>Outcome of Endodontic Treatment and Retreatment With a Bioceramic Sealer</brief_title>
  <official_title>The Outcome of Endodontic Treatment and Retreatment With a Bioceramic Sealer: A Prospective Randomized Controlled Clinical Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Juan Gonzalo Olivieri</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitat Internacional de Catalunya</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a prospective randomized controlled study of patients who come to the&#xD;
      University. The aim is to evaluate the success rate of treatment and retreatment of canals&#xD;
      using BioRoot ™ RCS cement compared with AH Plus up to 6 years of follow-up. The null&#xD;
      hypothesis is that there will be no statistically significant differences in rates of&#xD;
      successful treatment of root canals filled with BioRoot ™ RCS compared to gutta-percha and AH&#xD;
      Plus sealer.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 20, 2019</start_date>
  <completion_date type="Anticipated">January 2027</completion_date>
  <primary_completion_date type="Anticipated">January 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical post-operative pain</measure>
    <time_frame>Immediately post-treatment.</time_frame>
    <description>VAS score of patient' level of pain, from no pain to extreme pain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical post-operative pain</measure>
    <time_frame>4 hours post-treatment</time_frame>
    <description>VAS score of patient' level of pain, from no pain to extreme pain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical post-operative pain</measure>
    <time_frame>24 hours post treatment</time_frame>
    <description>VAS score of patient' level of pain, from no pain to extreme pain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical post-operative pain</measure>
    <time_frame>48 hours post treatment</time_frame>
    <description>VAS score of patient' level of pain, from no pain to extreme pain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical signs or symptoms of periapical disease</measure>
    <time_frame>1 year</time_frame>
    <description>Absence/presence of clinical signs or symptoms of periapical disease</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical signs or symptoms of periapical disease</measure>
    <time_frame>2 years</time_frame>
    <description>Absence/presence of clinical signs or symptoms of periapical disease</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical signs or symptoms of periapical disease</measure>
    <time_frame>4 years</time_frame>
    <description>Absence/presence of clinical signs or symptoms of periapical disease</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical signs or symptoms of periapical disease</measure>
    <time_frame>6 years</time_frame>
    <description>Absence/presence of clinical signs or symptoms of periapical disease</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Radiographic periapical healing</measure>
    <time_frame>1 year</time_frame>
    <description>Absence/presence of radiographic apical periodontitis + PAI changes when compared with post-treatment radiograph</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Radiographic periapical healing</measure>
    <time_frame>2 years</time_frame>
    <description>Absence/presence of radiographic apical periodontitis + PAI changes when compared with post-treatment radiograph</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Radiographic periapical healing</measure>
    <time_frame>4 years</time_frame>
    <description>Absence/presence of radiographic apical periodontitis + PAI changes when compared with post-treatment radiograph</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Radiographic periapical healing</measure>
    <time_frame>6 years</time_frame>
    <description>Absence/presence of radiographic apical periodontitis + PAI changes when compared with post-treatment radiograph</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Correlation of prognostic factors and clinical signs or symptoms of periapical disease</measure>
    <time_frame>1 year</time_frame>
    <description>Correlation of Pre-treatment symptomatology, post-operative pain, radiographic periapical lesion size, being an abutment, and presence of antagonist with having clinical signs or symptoms of periapical disease</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation of prognostic factors and clinical signs or symptoms of periapical disease</measure>
    <time_frame>2 years</time_frame>
    <description>Correlation of Pre-treatment symptomatology, post-operative pain, radiographic periapical lesion size, being an abutment, and presence of antagonist with having clinical signs or symptoms of periapical disease</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation of prognostic factors and clinical signs or symptoms of periapical disease</measure>
    <time_frame>4 years</time_frame>
    <description>Correlation of Pre-treatment symptomatology, post-operative pain, radiographic periapical lesion size, being an abutment, and presence of antagonist with having clinical signs or symptoms of periapical disease</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation of prognostic factors and clinical signs or symptoms of periapical disease</measure>
    <time_frame>6 years</time_frame>
    <description>Correlation of Pre-treatment symptomatology, post-operative pain, radiographic periapical lesion size, being an abutment, and presence of antagonist with having clinical signs or symptoms of periapical disease</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation of prognostic factors and radiographic periapical healing</measure>
    <time_frame>1 year</time_frame>
    <description>Pre-treatment symptomatology, post-operative pain, radiographic periapical lesion size, being an abutment, and presence of antagonist, in relation to radiographic periapical Correlation of Pre-treatment symptomatology, post-operative pain, radiographic periapical lesion size, being an abutment, and presence of antagonist with radiographic periapical healing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation of prognostic factors and radiographic periapical healing</measure>
    <time_frame>2 years</time_frame>
    <description>Correlation of Pre-treatment symptomatology, post-operative pain, radiographic periapical lesion size, being an abutment, and presence of antagonist with radiographic periapical healing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation of prognostic factors and radiographic periapical healing</measure>
    <time_frame>4 years</time_frame>
    <description>Correlation of Pre-treatment symptomatology, post-operative pain, radiographic periapical lesion size, being an abutment, and presence of antagonist with radiographic periapical healing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation of prognostic factors and radiographic periapical healing</measure>
    <time_frame>6 years</time_frame>
    <description>Correlation of Pre-treatment symptomatology, post-operative pain, radiographic periapical lesion size, being an abutment, and presence of antagonist with radiographic periapical healing</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">220</enrollment>
  <condition>Endodontic Disease</condition>
  <condition>Endodontically Treated Teeth</condition>
  <arm_group>
    <arm_group_label>Primary root canal treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Primary root canal treatment sealed with guttapercha and AH Plus® or BioRoot RCS® root canal sealers</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Secondary root canal treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Secondary root canal treatment sealed with guttapercha and AH Plus® or BioRoot RCS® root canal sealers</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>BioRoot RCS® root canal sealer</intervention_name>
    <description>Root canal obturation with guttapercha and BioRoot RCS® root canal sealer</description>
    <arm_group_label>Primary root canal treatment</arm_group_label>
    <arm_group_label>Secondary root canal treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>AH Plus® root canal sealer</intervention_name>
    <description>Root canal obturation with guttapercha and AH Plus® root canal sealer</description>
    <arm_group_label>Primary root canal treatment</arm_group_label>
    <arm_group_label>Secondary root canal treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients that demonstrate understanding of the study and willingness to participate as&#xD;
             evidenced by signing the voluntary informed consent and received a signed and dated&#xD;
             copy of the informed consent form.&#xD;
&#xD;
          -  Understands and is willing to comply with all study procedures and restrictions.&#xD;
&#xD;
          -  Not presence of clinically significant and relevant abnormalities of clinical history&#xD;
             or oral examination.&#xD;
&#xD;
          -  Diagnosis of irreversible pulpitis or apical symptomatic / asymptomatic periodontitis.&#xD;
&#xD;
          -  Retreatment cases due to an endodontic failure.&#xD;
&#xD;
          -  Single or bi-radicular teeth.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  General: Patients with systemic diseases, diabetes, immunocompromised and pregnant&#xD;
             women, or any clinically significant or relevant oral abnormalities.&#xD;
&#xD;
          -  Specific: root resorption, root fractures, impossibility of restoration and cases were&#xD;
             primary or secondary root canal treatment is not the treatment of choice.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Universitat Internacional de Catalunya</name>
      <address>
        <city>Sant Cugat Del Vallès</city>
        <state>Barcelona</state>
        <zip>08195</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juan G. Olivieri, DDS, PhD</last_name>
      <phone>935042000</phone>
      <email>jgolivieri@uic.es</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>May 21, 2020</study_first_submitted>
  <study_first_submitted_qc>August 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 27, 2020</study_first_posted>
  <last_update_submitted>August 27, 2020</last_update_submitted>
  <last_update_submitted_qc>August 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 31, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Universitat Internacional de Catalunya</investigator_affiliation>
    <investigator_full_name>Juan Gonzalo Olivieri</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <keyword>Primary root canal treatment</keyword>
  <keyword>Secondary root canal treatment</keyword>
  <keyword>Outcome</keyword>
  <keyword>Root canal sealer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tooth, Nonvital</mesh_term>
    <mesh_term>Dental Pulp Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

